INBS (Intelligent Bio Solutions) Tariff Resilience Score: 6/10 (As of Jul. 05, 2026)


INBS Intelligent Bio Solutions Inc INBS
44 GF Score
Price $2.24
GF Value $3.93
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Intelligent Bio Solutions Tariff Resilience Score?

Intelligent Bio Solutions INBS +0.45% 44 Tariff Resilience Score is 6 as of Jul. 05, 2026. GuruFocus rates INBS with a GF Score™ of 44/100 and a GF Value™ of $3.93 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 837 Medical Devices & Instruments companies, Intelligent Bio Solutions ranks better than 91.04% on this metric.

Intelligent Bio Solutions has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Intelligent Bio Solutions has Intelligent Bio Solutions, involved in biotech, has moderate tariff exposure due to its global supply chain. However, its focus on innovation and R&D provides some resilience. Historical impacts have been limited, with some mitigation strategies available.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Intelligent Bio Solutions might have Average Resilient.

Intelligent Bio Solutions  (NAS:INBS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Intelligent Bio Solutions Tariff Resilience Score Related Terms

INBS vs ITOC, WOK, BMRA: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Intelligent Bio Solutions's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intelligent Bio Solutions Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Intelligent Bio Solutions's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Intelligent Bio Solutions's Tariff Resilience Score falls into.


INBS
44GF Score
Intelligent Bio Solutions Inc INBS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Intelligent Bio Solutions (INBS) has a Tariff Resilience Score of 6 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Intelligent Bio Solutions ranks #75 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 9%.
Is Intelligent Bio Solutions' Tariff Resilience Score too high?
Intelligent Bio Solutions' current Tariff Resilience Score is 6. Based on the distribution chart, Intelligent Bio Solutions ranks #75 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Intelligent Bio Solutions has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Intelligent Bio Solutions' Tariff Resilience Score compare to ITOC and WOK?
According to the Medical Devices & Instruments industry distribution chart, Intelligent Bio Solutions ranks #75 out of 837 companies for Tariff Resilience Score. This places Intelligent Bio Solutions in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Intelligent Bio Solutions's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligent Bio Solutions stock overvalued right now?
Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Possible Value Trap. The stock's GF Value™ is $3.93, compared to a current price of $2.24 — trading 43% below its estimated fair value. The current Tariff Resilience Score is 6. Intelligent Bio Solutions' overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current Tariff Resilience Score is 6 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intelligent Bio Solutions (INBS) Overvalued in 2026?

Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued. The current stock price of $2.24 is trading 43% below its estimated GF Value™ of $3.93. GuruFocus considers Intelligent Bio Solutions to be Possible Value Trap.

Key valuation signals for INBS:

  • Tariff Resilience Score: 6
  • GF Value™: $3.93 vs. price of $2.24 (43% below fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intelligent Bio Solutions Business Description

Address 135 West, 41ST Street, 5th Floor, New York, NY, USA, 10036
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
44GF Score

Get the complete analysis for INBS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.24
Price
$3.93
GF Value